mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.01 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.01 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.01 |
mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.02 |
mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
QL-XII-61 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.02 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.02 |